✦ LIBER ✦

Phase II trial of etoposide and split-dose cisplatin and pirarubicin (THP) in small cell lung cancer (SCLC)

✍ Scribed by Matsui, Yusaku; Kado, Masao; Izumi, Takateru

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High remission rates in the treatment of

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J; Brugiere, O; Vannetzel, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Cisplatin, etoposide and gemcitabine in

✍ De Marinis, F.; Cortesi, E.; Gareri, R.; Ripanti, P.; Grifalchi, F.; Cipri, A.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Ifosfamide, epirubicin and vincristine a

✍ Rodrígeuz, CA; Martín, G; López, Y; Cruz, JJ 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 117 KB

40 Prospective randomized trial of high-

✍ González-Larriba, J.L.; Artal, A.; Barneto, I.; Gómez-Codina, J.; Isla, D.; Carr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 144 KB